Current Clinical Trials

Sneeze, Wheeze and Itch Associates, LLC

Go Back

Atopic Dermatitis/Eczema

  • Number
  • Type
  • Age Range
  • Length of Study
  • Compensation*
  • KPL-716
  • Atopic Dermatitis/Eczema
  • 18 - 60 years old
  • Up to 168 days
  • $2300


*Qualified participants may receive compensation for time and travel, up to the amount listed.

A Phase Ib, Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of KPL-716 in Subjects with Atopic Dermatitis and Uremic Pruritus.

Call center for more details and to see if you may qualify.